Pharmacokienetic studies on Docetaxel in breast cancer Patients
Role of Cytochrome 3A4 in Relation to Activity
(Sprache: Englisch)
Worldwide, breast cancer is the leading type of cancer in women. Among Egyptian women breast cancer showed the highest frequencies among all cancers. Docetaxel (DCX) is one of the chemotherapy medication used to treat breast cancer which mainly metabolized...
Leider schon ausverkauft
versandkostenfrei
Buch
55.90 €
27 DeutschlandCard Punkte
sammeln
- Lastschrift, Kreditkarte, Paypal, Rechnung
- Kostenlose Rücksendung
- Ratenzahlung möglich
Produktdetails
Produktinformationen zu „Pharmacokienetic studies on Docetaxel in breast cancer Patients “
Klappentext zu „Pharmacokienetic studies on Docetaxel in breast cancer Patients “
Worldwide, breast cancer is the leading type of cancer in women. Among Egyptian women breast cancer showed the highest frequencies among all cancers. Docetaxel (DCX) is one of the chemotherapy medication used to treat breast cancer which mainly metabolized in the liver by cytochrome3A4. The present study was conducted to study pharmacokinetic and pharmacodynamic properties of DCX in Egyptian breast cancer patients and the interpatient variability of cytochrome3A4 activity, as estimated using urinary metabolites of exogenous cortisol. The practical work was take place in NCI, Cairo University, Egypt.
Bibliographische Angaben
- Autor: Mervat Omran
- 2017, 140 Seiten, Maße: 22 cm, Kartoniert (TB), Englisch
- Verlag: Noor Publishing
- ISBN-10: 3330971541
- ISBN-13: 9783330971547
Sprache:
Englisch
Kommentar zu "Pharmacokienetic studies on Docetaxel in breast cancer Patients"
0 Gebrauchte Artikel zu „Pharmacokienetic studies on Docetaxel in breast cancer Patients“
| Zustand | Preis | Porto | Zahlung | Verkäufer | Rating |
|---|
Schreiben Sie einen Kommentar zu "Pharmacokienetic studies on Docetaxel in breast cancer Patients".
Kommentar verfassen